Shamla Pharmaceutical Industries has announced it will build a manufacturing facility in King Abdullah Economic City (KAEC), Saudi Arabia.
Gerresheimer has reported sales and earnings growth for the fiscal year 2010, citing demand from customers in the pharmaceutical industry as key.
QPS Holdings has acquired Taiwan’s Center of Toxicology and Preclinical Sciences (CTPS), continuing its expansion in the region’s rapidly expanding drug development sector.
Adoption of a pragmatic, real-world research culture would bridge the gap between discovery and treating the intended patients.
Variation between drug batches in developing countries poses “serious clinical implications” and should be tackled by regulators.
Global clinical research organisation (CRO), PRA International, has opened two new offices in Israel and the Ukraine.
Establishment of complex regulated preclinical studies in China is going to take a lot longer than expected, says CRL, with significant progress taking at least five years.
Albany Molecular Research Inc. (AMRI) has posted a fourth quarter loss for 2010 after charges relating to a non-cash goodwill and fixed asset impairment of $35.2m.
PPD and Charles River Laboratories (CRL) finished 2010 with very different quarters, each posting results that illustrate trends within the CRO sector.
An upgrade to ClearTrial software allows users to tailor the system to their requirements by incorporating in-house forecasting algorithms.
Novasep and instrAction have partnered to develop improved methods for the production of taxane-based active pharmaceutical ingredients (API) citing growing demand for cancer treatments as key driver.
The United States Pharmacopeoia (USP) will help regulators in sub-Saharan Africa ensure drug quality in a new scheme designed to boost testing and analysis capacity.
A bill requiring biopharm manufacturers to give the FDA early notification of potential drug shortages has been introduced to the US Senate.
More collaborative biosurveillance could save billions of dollars and millions of lives by, for example, cutting pandemic strain isolation times.
Lotus Pharmaceuticals’ new HQ in Beijing, China will be even bigger after the firm announces plans for employee apartments.